FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin …
Sep 20, 2024 · The PBMs Caused the Burden of High Insulin List Prices to Shift to Vulnerable Patients, the FTC Alleges. According to the complaint, as insulin list prices escalated, the PBMs collected rebates that, in principle, should have significantly reduced the cost of insulin drugs for patients at the pharmacy counter.
Federal Trade Commission sues largest drug middlemen for …
Sep 20, 2024 · The Federal Trade Commission took action Friday against the nation’s three largest pharmacy benefit managers, accusing the companies of artificially inflating insulin list prices that...
FTC sues pharmacy benefit managers for inflating price of insulin …
Sep 21, 2024 · The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially inflated the cost of insulin.
Drug middlemen illegally drive up the cost of insulin, FTC says
Sep 20, 2024 · Federal regulators are accusing the country's three largest pharmacy benefit managers of illegally driving up the cost of insulin in the U.S., while making it harder for patients to...
Feds sue pharmacy gatekeepers over high insulin costs
Sep 20, 2024 · Congress capped insulin prices for Medicare patients at $35 per month in the Inflation Reduction Act, and Biden has urged lawmakers to expand the cap to private insurance plans.
FTC sues drug 'gatekeepers' over high insulin prices - USA TODAY
Sep 20, 2024 · The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of steering diabetes patients toward higher-priced insulin to reap...
US FTC Sues Drug 'Gatekeepers' Over High Insulin Prices - U.S. News
Sep 20, 2024 · (Reuters) -The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of steering diabetes patients towards higher priced insulin...
FTC And Pharmacy Benefit Managers Square Off For Legal Battle
Oct 7, 2024 · The Federal Trade Commission filed a lawsuit last month against the pharmacy benefit managers CVS Caremark, Express Scripts and OptumRx for their allegedly anticompetitive practices that...
High insulin prices spur a federal lawsuit against three pharmacy ...
Sep 20, 2024 · The federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators say has made the price of insulin soar for diabetic patients.
US FTC sues drug 'gatekeepers' over high insulin prices
Sept 20 (Reuters) - The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of steering diabetes patients towards higher priced...
- Some results have been removed